1. Scrip
  2. >>R&D
  3. >>Clinical Trials

Publisher’s Spotlight: Citeline Awards Honor R&D Excellence

 
• By Mary Jo Laffler

Pharma Intelligence congratulates the winners of the 2021 Citeline Awards. 

Picture showing group of friends having fun with sparklers - Image
The 2021 Citeline Awards were held 8 April in Boston • Source: Shutterstock

In recognition of the unprecedented accomplishments of the biopharmaceutical industry over the past couple years, the winners of the 2021 Citeline Awards include numerous contributions to the COVID-19 response, representing the rapid innovation and dedication of individuals across the industry. And, given the need to adapt clinical trials to pandemic circumstances, several awards recognized new technologies aimed at virtual monitoring and integrated research solutions.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

AstraZeneca COPD Drug Breztri Breezes Through Asthma Trials

 
• By Kevin Grogan

The triple therapy improves lung function in the Phase III KALOS and LOGOS studies

DIA Korea: Medical Turmoil, Global Factors Blunt Korea’s Trial Edge

 
• By Jung Won Shin

DIA Korea hears how multiple domestic and global factors are affecting the environment for clinical trials in South Korea, and what actions may be taken to address this.

Moderna Punts On US Vaccine Policy Changes, Will Focus More On Cancer

 
• By Joseph Haas

On its Q1 earnings call, Moderna avoided criticizing policy changes affecting vaccines but de-emphasized its flu/COVID-19 vaccine for under-50 and prioritized cancer programs.

GSK Talks Up Nucala COPD Hospitalization Data In Challenge To Dupixent

 
• By Kevin Grogan

As the PDUFA date for the UK major’s IL-5 inhibitor draws close.

More from R&D